Company / FCF Margin
UTAH MEDICAL PRODUCTS INC FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
43.1%
FY2025
5-year range
35.2% / 176.8%
FY2021-FY2025
Trend
+10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching 43.1%.
Based on SEC 10-K filings.
43.1% in FY2025 with a 5-year CAGR of +4.0%.
Improved from 42.1% to 43.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -133.7pp
- 5-Year Change
- +4.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 10.8% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 43.1% | +10.8% |
| FY2024 | 38.9% | -7.6% |
| FY2023 | 42.1% | -76.2% |
| FY2022 | 176.8% | +402.2% |
| FY2021 | 35.2% | -10.0% |
| FY2020 | 39.1% | +5.8% |
| FY2019 | 37.0% | +29.3% |
| FY2018 | 28.6% | -15.7% |
| FY2017 | 33.9% | -1.9% |
| FY2016 | 34.6% | +17.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026